32-76% Reduction in cns leukemia with a pharmacokinetically-derived intrathecal methotrexate (IT MTX) dosage regimen and a lower cranial radiation dose

A. Bleyer, P. Coccia, H. Sather

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)C-520
JournalProceedings of the American Society of Clinical Oncology
VolumeVol. 1
StatePublished - Jan 1 1982

Fingerprint

Methotrexate
Leukemia
Radiation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{1945989f542c406e9901831607154c5b,
title = "32-76{\%} Reduction in cns leukemia with a pharmacokinetically-derived intrathecal methotrexate (IT MTX) dosage regimen and a lower cranial radiation dose",
author = "A. Bleyer and P. Coccia and H. Sather",
year = "1982",
month = "1",
day = "1",
language = "English (US)",
volume = "Vol. 1",
pages = "C--520",
journal = "Proceedings of the American Society of Clinical Oncology",

}

TY - JOUR

T1 - 32-76% Reduction in cns leukemia with a pharmacokinetically-derived intrathecal methotrexate (IT MTX) dosage regimen and a lower cranial radiation dose

AU - Bleyer, A.

AU - Coccia, P.

AU - Sather, H.

PY - 1982/1/1

Y1 - 1982/1/1

UR - http://www.scopus.com/inward/record.url?scp=0020382317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020382317&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0020382317

VL - Vol. 1

SP - C-520

JO - Proceedings of the American Society of Clinical Oncology

JF - Proceedings of the American Society of Clinical Oncology

ER -